PetMed Express CFO Bruce Rosenbloom Sells 6,666 Shares (PETS)
PetMed Express (NASDAQ:PETS) CFO Bruce Rosenbloom unloaded 6,666 shares of PetMed Express stock on the open market in a transaction dated Wednesday, September 11th. The shares were sold at an average price of $16.21, for a total transaction of $108,055.86. Following the completion of the sale, the chief financial officer now directly owns 43,184 shares in the company. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
PETS has been the subject of a number of recent research reports. Analysts at Zacks reiterated an “outperform” rating on shares of PetMed Express (NASDAQ:PETS) in a research note to investors on Tuesday, September 3rd. They now have a $18.00 price target on the stock. Separately, analysts at Piper Jaffray Cos. raised their price target on shares of PetMed Express (NASDAQ:PETS) from $13.00 to $16.00 in a research note to investors on Tuesday, July 23rd. They now have a “neutral” rating on the stock. Finally, analysts at Jefferson Research downgraded shares of PetMed Express (NASDAQ:PETS) from a “hold” rating to a “sell” rating in a research note to investors on Friday, July 12th.
One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. PetMed Express has an average rating of “Hold” and a consensus price target of $17.00.
Shares of PetMed Express (NASDAQ:PETS) traded down 0.62% on Thursday, hitting $16.6464. The stock had a trading volume of 210,304 shares. PetMed Express has a 1-year low of $9.63 and a 1-year high of $17.75. The stock has a 50-day moving average of $15.96 and a 200-day moving average of $13.97. The company has a market cap of $320.4 million and a P/E ratio of 18.61.
PetMed Express (NASDAQ:PETS) last released its earnings data on Monday, July 22nd. The company reported $0.24 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.22 by $0.02. The company had revenue of $74.20 million for the quarter, compared to the consensus estimate of $69.55 million. During the same quarter in the prior year, the company posted $0.20 earnings per share. The company’s quarterly revenue was up 7.5% on a year-over-year basis. Analysts expect that PetMed Express will post $0.91 EPS for the current fiscal year.
PetMed Express, Inc (NASDAQ:PETS) and its subsidiaries, doing business as 1-800-PetMeds, is a pet pharmacy.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.